Insider filing · MAZE
Harold Bernstein
President, R&D & CMO
profile →
Maze Therapeutics, Inc.
MAZE · Healthcare · 41 filings in 24 months
ticker →
Harold Bernstein sold $1.8M of Maze Therapeutics (MAZE)
Executed Dec 29 2025, disclosed Dec 31 2025, 2 days later.
Value, as filed
$1.8M
45,000 sh across 2 lots
Executed
Dec 29 2025
the trade date, as filed
Disclosed
Dec 31 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HBHarold Bernstein (President, R&D & CMO) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $1.8M of MAZE (45,000 sh across 2 lots, as filed), executed Dec 29 2025.
The name
MAZEHealthcare · Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidne…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Harold Bernstein in MAZE
MAZESALE
Maze Therapeutics, Inc.
$435K16,141 sh × $26.93
Exec Oct 1
Filed Oct 2 · 4:09 PM ET MAZESALE Maze Therapeutics, Inc. $255K
9,705 sh × $26.22
Exec Sep 4
Filed Sep 8 · 4:20 PM ET MAZESALE Maze Therapeutics, Inc. $252K
9,611 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 4:22 PM ET MAZESALE Maze Therapeutics, Inc. $426K
16,141 sh × $26.36
Exec Sep 1
Filed Sep 3 · 4:24 PM ET MAZESALE Maze Therapeutics, Inc. $446K
16,142 sh × $27.61
Exec Aug 13
Filed Aug 14 · 4:54 PM ET MAZESALE Maze Therapeutics, Inc. $400K
13,409 sh × $29.86
Exec Jul 1
Filed Jul 2 · 4:29 PM ET MAZESALE Maze Therapeutics, Inc. $339K
13,253 sh × $25.57
Exec Jun 1
Filed Jun 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. $393K
15,000 sh × $26.22
Exec May 14
Filed May 18 · 5:30 PM ET